Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
gemcitabine (gemzar) (1 trial)
Carcinoma (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasms, Unknown Primary (Phase 2)
Trials (1 total)
Trial APIs (1 total)